Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients. 2005

Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
Laboratoire de Virologie and Service d'Urologie, Hôpital Lapeyronie, Montpellier, France.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009360 Neoplastic Cells, Circulating Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. Circulating Neoplastic Cells,Embolic Tumor Cells,Embolism, Tumor,Neoplasm Circulating Cells,Tumor Cells, Embolic,Cells, Neoplasm Circulating,Circulating Cells, Neoplasm,Circulating Tumor Cells,Cell, Circulating Neoplastic,Cell, Circulating Tumor,Cell, Embolic Tumor,Cell, Neoplasm Circulating,Cells, Circulating Neoplastic,Cells, Circulating Tumor,Cells, Embolic Tumor,Circulating Neoplastic Cell,Circulating Tumor Cell,Embolic Tumor Cell,Embolisms, Tumor,Neoplasm Circulating Cell,Neoplastic Cell, Circulating,Tumor Cell, Circulating,Tumor Cell, Embolic,Tumor Cells, Circulating,Tumor Embolism,Tumor Embolisms
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
October 1999, European urology,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
April 1992, British journal of urology,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
June 1993, British journal of urology,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
August 1996, British journal of cancer,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
April 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
September 1990, Presse medicale (Paris, France : 1983),
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
April 1997, Deutsche medizinische Wochenschrift (1946),
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
November 2014, Expert review of anticancer therapy,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
October 2020, Clinical nuclear medicine,
Catherine Alix-Panabières, and Xavier Rebillard, and Jean-Paul Brouillet, and Eric Barbotte, and François Iborra, and Bruno Segui, and Thierry Maudelonde, and Colette Jolivet-Reynaud, and Jean-Pierre Vendrell
March 2000, The Journal of urology,
Copied contents to your clipboard!